Leclercq IA - Search Results

1

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Leclercq IA, et al. J Hepatol. 2007 Jul;47(1):142-56. doi: 10.1016/j.jhep.2007.04.002. Epub 2007 Apr 16. J Hepatol. 2007. PMID: 17512085 Review.

2

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

Leclercq I, Horsmans Y, Desager JP, Delzenne N, Geubel AP. Leclercq I, et al. J Hepatol. 1998 Mar;28(3):410-6. doi: 10.1016/s0168-8278(98)80314-0. J Hepatol. 1998. PMID: 9551678

3

The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes.

Lambotte L, Li B, Leclercq I, Sempoux C, Saliez A, Horsmans Y. Lambotte L, et al. J Hepatol. 2000 Jun;32(6):940-5. doi: 10.1016/s0168-8278(00)80098-7. J Hepatol. 2000. PMID: 10898314

4

Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leclercq IA, et al. J Hepatol. 2002 Aug;37(2):206-13. doi: 10.1016/s0168-8278(02)00102-2. J Hepatol. 2002. PMID: 12127425

5

Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats.

Stärkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y. Stärkel P, et al. J Hepatol. 2003 Oct;39(4):538-46. doi: 10.1016/s0168-8278(03)00360-x. J Hepatol. 2003. PMID: 12971963

6

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.

Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y. Leclercq IA, et al. J Hepatol. 2004 Dec;41(6):926-34. doi: 10.1016/j.jhep.2004.08.010. J Hepatol. 2004. PMID: 15582125

7

Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis.

Stärkel P, De Saeger C, Leclercq I, Strain A, Horsmans Y. Stärkel P, et al. J Hepatol. 2005 Oct;43(4):687-95. doi: 10.1016/j.jhep.2005.03.024. J Hepatol. 2005. PMID: 16098628

8

Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin.

Leclercq IA, Vansteenberghe M, Lebrun VB, VanHul NK, Abarca-Quinones J, Sempoux CL, Picard C, Stärkel P, Horsmans YL. Leclercq IA, et al. Lab Invest. 2006 Nov;86(11):1161-71. doi: 10.1038/labinvest.3700474. Epub 2006 Sep 18. Lab Invest. 2006. PMID: 16983330 Free article.

9

Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone.

Leclercq IA, Lebrun VA, Stärkel P, Horsmans YJ. Leclercq IA, et al. Lab Invest. 2007 Jan;87(1):56-65. doi: 10.1038/labinvest.3700489. Epub 2006 Oct 30. Lab Invest. 2007. PMID: 17075577 Free article.

10

Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.

Da Silva Morais A, Abarca-Quinones J, Horsmans Y, Stärkel P, Leclercq IA. Da Silva Morais A, et al. Among authors: leclercq ia. Int J Mol Med. 2007 Jan;19(1):105-12. Int J Mol Med. 2007. PMID: 17143554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters